2022 Aug 4;387(5):433-443
Large portion formats, hyper-palatable coatings, layered crunch textures, rapid melt characteristics, and high-glycaemic carbohydrate systems can all contribute to reduced portion awareness and rebound hunger shortly after eating. Holgate argues that the transition off GLP-1s could expose a new challenge for manufacturers
After acclimation, six hundred zebrafish were randomly divided into 2 groups (3 tanks per group, 100 fish per tank): control group and carnitine group (Fig
Current UK professional guidance emphasises: Patients should inform their surgical team and anaesthetist that they are taking a GLP-1 medication as soon as surgery is planned Healthcare professionals should specifically ask about GLP-1 use during preoperative assessment, as patients may not recognise these medications as relevant to their surgery The decision to continue or pause GLP-1 therapy should be made on an individual risk-based assessment , considering the type of surgery, the specific GLP-1 agent, dose escalation status, presence of gastrointestinal symptoms, and the patient's clinical circumstances Many patients can safely continue GLP-1 medications perioperatively with appropriate precautions, while those at higher risk may benefit from temporary cessation The Summary of Product Characteristics (SmPC) for GLP-1 medications notes the delayed gastric emptying effect, which anaesthetists consider when planning perioperative care
How long do I need to take retatrutide
aureus worsens eczema through multiple mechanisms: it produces superantigens that amplify the immune response, it damages the skin barrier directly, and it has evolved sophisticated resistance mechanisms against the few antimicrobial peptides that remain
